Arthritic Therapeutic Market Report 2025-2034: Industry Overview, Trends, And Forecast Analysis

The Arthritic Therapeutic Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Current Arthritic Therapeutic Market Size and Its Estimated Growth Rate?
The arthritic therapeutic market has shown strong growth in recent years. It is expected to rise from $68.1 billion in 2024 to $72.44 billion in 2025, with a CAGR of 6.4%. This growth in the past can be credited to an increasing number of diagnosed patients, greater awareness of symptoms, a higher prevalence of obesity, improved diagnostic capabilities, and advancements in treatment outcomes.

The arthritic therapeutic market is anticipated to witness robust growth over the next few years, reaching $91.72 billion by 2029 at a CAGR of 6.1%. This growth can be attributed to enhanced TH*Care infrastructure, supportive government initiatives, favorable regulatory policies, a growing focus on personalized medicine, and a shift toward patient-centric TH*Care models. Major trends expected in the forecast period include an increased focus on biosimilars, a transition toward biologics, greater availability of biosimilars, a preference for parenteral administration, and the expansion of online pharmacies.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19297

How Are Emerging Segments Shaping the Arthritic Therapeutic Market Landscape?
The arthritic therapeuticmarket covered in this report is segmented -

1) By Drug Class: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Xanthine Oxidase Inhibitors, Other Drug Classes
2) By Route Of Administration: Oral, Parenteral, Topical
3) By Type: Psoriatic Arthritis, Rheumatoid Arthritis, Osteoarthritis, Gout, Other Types
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:
1) By Tumor Necrosis Factor (TNF) Inhibitors: Adalimumab, Etanercept, Infliximab, Certolizumab Pegol, Golimumab
2) By Interleukin Inhibitors: Interleukin-6 (IL-6) Inhibitors, Interleukin-1 (IL-1) Inhibitors, Interleukin-17 (IL-17) Inhibitors, Interleukin-23 (IL-23) Inhibitors
3) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Naproxen, Diclofenac, Celecoxib, Meloxicam
4) By Corticosteroids: Prednisone, Methylprednisolone, Hydrocortisone, Dexamethasone
5) By Xanthine Oxidase Inhibitors: Allopurinol, Febuxostat
6) By Other Drug Classes: Disease-Modifying Antirheumatic Drugs (DMARDs), Janus Kinase (JAK) Inhibitors, Biologic DMARDs, Topical Analgesics, Opioid Pain Medications

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19297&type=smp

Which Growth Factors Are Influencing Arthritic Therapeutic Market Expansion?
The increasing prevalence of arthritis is expected to accelerate the growth of the arthritic therapeutic market. Arthritis encompasses over 100 conditions, mainly involving joint pain and inflammation. The rising incidence of arthritis is attributed to an aging population, higher obesity rates, and lifestyle factors contributing to joint stress. Treatments for arthritis aim to alleviate symptoms, reduce inflammation, and improve joint function, enhancing the overall quality of life for patients. For instance, in June 2024, the Australian Institute of Health and Welfare reported that around 514,000 people in Australia were living with rheumatoid arthritis in 2022, representing 2.0% of the population. This rise in arthritis cases is fueling the growth of the arthritic therapeutic market.

Who Are the Dominant Players Across Different Arthritic Therapeutic Market Segments?
Major companies operating in the arthritic therapeutic market are Pfizer Inc., Johnson & Johnson, Hoffmann-La Roche Ltd, Merck & Co Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca Pharma AB, GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Zimmer Biomet Holdings Inc., UCB Pharma S.A., Incyte Corporation, Celltrion Inc., Mallinckrodt Pharmaceuticals, Genentech Inc., Anika Therapeutics Inc., Medac GmbH

What Are the Latest Developing Trends in the Arthritic Therapeutic Market?
In the arthritis therapeutic market, companies are focusing on biosimilar monoclonal antibody-based therapies to enhance treatment efficacy and reduce costs. A notable example is Bio-Thera Solutions Ltd., which launched TOFIDENCE, a biosimilar monoclonal antibody for treating rheumatoid arthritis and related conditions. This development allows patients to access more affordable treatments that replicate the therapeutic benefits of the original monoclonal antibody, ACTEMRA, offering a lower-cost alternative with similar effectiveness.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/arthritic-therapeutic-global-market-report

Which Geographic Regions Are Expected to Dominate the Arthritic Therapeutic Market in the Coming Years?
North America was the largest region in the arthritic therapeutic market in 2024. The regions covered in the arthritic therapeutic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Arthritic Therapeutic Market?
2. What is the CAGR expected in the Arthritic Therapeutic Market?
3. What Are the Key Innovations Transforming the Arthritic Therapeutic Industry?
4. Which Region Is Leading the Arthritic Therapeutic Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.